日本重组蛋白市场报告（按产品、应用、最终用户和地区）2025-2033

2024年，日本重组蛋白市场规模达2.657亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到5.737亿美元，2025-2033年期间的复合年增长率（CAGR）为8.9%。单株抗体、疫苗和治疗性蛋白质等生物製药的蓬勃发展，正推动着市场的发展，这些生物製药越来越多地被用于治疗各种疾病，包括癌症、自体免疫疾病和传染病。

重组蛋白是透过结合不同来源的遗传物质（通常是来自具有产生特定蛋白质能力的生物体的DNA和宿主生物体用于蛋白质生产的细胞机制）而产生的人工工程蛋白质。该过程是生物技术和製药行业不可或缺的一部分，可用于大规模生产用于各种应用的特定蛋白质。为了创建重组蛋白，科学家将所需的基因序列插入宿主生物体，例如细菌、酵母或哺乳动物细胞。一旦宿主生物体吸收了外来DNA，它就会根据插入的遗传指令开始生产目标蛋白质。重组蛋白具有广泛的应用，包括生产治疗药物（例如胰岛素或疫苗）、研究工具（例如酵素和抗体）以及用于各种製程（例如生物燃料生产或食品加工）的工业酵素。它们的生产具有精确控制、可扩展性和纯度，使其成为医疗、科学和工业领域发展的关键。

日本重组蛋白市场趋势：

推动日本重组蛋白市场发展的因素很多。首先，癌症、糖尿病和自体免疫疾病等慢性疾病的发生率不断上升，使得透过重组DNA技术生产的治疗性蛋白质的需求日益增长。因此，製药公司正大力投资新型态生物製药的开发，推动市场发展。此外，基因工程和生物技术的进步也改进了重组蛋白的生产过程。哺乳动物和酵母细胞係等增强表达系统使得能够生产产量更高、品质更好的复杂蛋白质，从而推动了市场扩张。此外，蛋白质体学和基因组学领域研发活动的激增，也刺激了重组蛋白作为研究工具的需求。这些蛋白质对于研究基因功能、蛋白质-蛋白质相互作用和药物研发至关重要，从而促进了市场成长。此外，个人化医疗的采用以及双特异性抗体和融合蛋白的开发为治疗性蛋白质产业开闢了新的机会，预计将在预测期内推动日本重组蛋白市场的发展。

日本重组蛋白市场细分：

产品洞察：

• 抗体
• 荷尔蒙
• 生长因子
• 细胞因子
• 其他的

应用程式洞察：

• 药物研发
• 学术研究
• 生物技术研究
• 生物製药生产
• 其他的

最终用户洞察：

• 製药和生物製药公司
• 生技公司
• 学术和研究机构
• 合约研究组织
• 其他的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

• 日本重组蛋白市场迄今表现如何？未来几年将如何表现？
• COVID-19 对日本重组蛋白市场有何影响？
• 日本重组蛋白市场依产品划分是怎样的？
• 日本重组蛋白市场根据应用如何划分？
• 根据最终用户，日本重组蛋白市场是如何分類的？
• 日本重组蛋白市场的价值链分为哪些阶段？
• 日本重组蛋白的关键驱动因素和挑战是什么？
• 日本重组蛋白市场的结构是怎么样的？主要参与者是谁？
• 日本重组蛋白市场的竞争程度如何？

本报告回答的关键问题：

• 日本重组蛋白市场迄今表现如何？未来几年将如何表现？
• COVID-19 对日本重组蛋白市场有何影响？
• 日本重组蛋白市场依产品划分是怎样的？
• 日本重组蛋白市场根据应用如何划分？
• 根据最终用户，日本重组蛋白市场是如何分類的？
• 日本重组蛋白市场的价值链分为哪些阶段？
• 日本重组蛋白的关键驱动因素和挑战是什么？
• 日本重组蛋白市场的结构是怎么样的？主要参与者是谁？
• 日本重组蛋白市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

• 研究目标
• 利害关係人
• 资料来源
  • 主要来源
  • 次要来源
• 市场评估
  • 自下而上的方法
  • 自上而下的方法
• 预测方法

第三章：执行摘要

第四章：日本重组蛋白市场－简介

• 概述
• 市场动态
• 产业趋势
• 竞争情报

第五章：日本重组蛋白市场格局

• 历史与当前市场趋势（2019-2024）
• 市场预测（2025-2033）

第六章：日本重组蛋白市场-细分：依产品

• 抗体
  • 概述
• 荷尔蒙
  • 概述
• 生长因子
  • 概述
• 细胞因子
  • 概述
• 其他的

第七章：日本重组蛋白市场-细分：依应用

• 药物研发
  • 概述
• 学术研究
  • 概述
• 生物技术研究
  • 概述
• 生物製药生产
  • 概述
• 其他的

第 8 章：日本重组蛋白市场 - 细分：按最终用户

• 製药和生物製药公司
  • 概述
• 生技公司
  • 概述
• 学术和研究机构
  • 概述
• 合约研究组织
  • 概述
• 其他的

第九章：日本重组蛋白市场－竞争格局

• 概述
• 市场结构
• 市场参与者定位
• 最佳获胜策略
• 竞争仪錶板
• 公司评估象限

第十章：关键参与者简介

• Company A
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company B
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company C
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company D
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company E
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events

第 11 章：日本重组蛋白市场-产业分析

• 驱动因素、限制因素和机会
  • 概述
  • 驱动程式
  • 限制
  • 机会
• 波特五力分析
  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁
• 价值链分析

第 12 章：附录

Japan recombinant protein market size reached USD 265.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 573.7 Million by 2033, exhibiting a growth rate (CAGR) of 8.9% during 2025-2033. The inflating development of biopharmaceuticals, such as monoclonal antibodies, vaccines, and therapeutic proteins, which are increasingly being used to treat various illnesses, including cancer, autoimmune disorders, and infectious diseases, is driving the market.

Recombinant protein are artificially engineered proteins created by combining genetic material from different sources, typically DNA from one organism with the ability to produce a specific protein and the host organism's cellular machinery for protein production. This process is integral to the biotechnology and pharmaceutical industries, allowing the large-scale production of specific proteins for various applications. To create recombinant proteins, scientists insert the desired gene sequence into a host organism, like bacteria, yeast, or mammalian cells. Once the host organism takes up the foreign DNA, it begins producing the target protein according to the inserted genetic instructions. Recombinant proteins have diverse applications, including the production of therapeutic drugs (e.g., insulin or vaccines), research tools (e.g., enzymes and antibodies), and industrial enzymes for various processes (e.g., biofuel production or food processing). Their production allows for precise control, scalability, and purity, making them essential in advancing medical, scientific, and industrial fields.

Japan Recombinant Protein Market Trends:

Several factors drive the recombinant protein market in Japan. Firstly, the increasing incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders has created a growing demand for therapeutic proteins produced through recombinant DNA technology. Consequently, pharmaceutical companies are heavily investing in the development of novel biopharmaceuticals, propelling the market forward. Furthermore, advancements in genetic engineering and biotechnology have led to improved production processes for recombinant proteins. Enhanced expression systems, such as mammalian and yeast cell lines, have enabled the production of complex proteins with higher yields and better quality, driving market expansion. In addition to this, the surge in R&D activities in the field of proteomics and genomics has boosted the demand for recombinant proteins as research tools. These proteins are essential for studying gene function, protein-protein interactions, and drug discovery, fostering market growth. Moreover, the adoption of personalized medicine and the development of bi-specific antibodies and fusion proteins, which have opened up new opportunities in the therapeutic protein industry, is expected to drive the recombinant protein market in Japan during the forecast period.

Japan Recombinant Protein Market Segmentation:

Product Insights:

• Antibodies
• Hormones
• Growth Factors
• Cytokines
• Others

Application Insights:

• Drug Discovery and Development
• Academic Research
• Biotechnology Research
• Biopharmaceutical Production
• Others

End User Insights:

• Pharmaceutical and Biopharmaceutical Companies
• Biotechnology Companies
• Academic and Research Institutes
• Contract Research Organization
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan recombinant protein market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan recombinant protein market?
• What is the breakup of the Japan recombinant protein market on the basis of product?
• What is the breakup of the Japan recombinant protein market on the basis of application?
• What is the breakup of the Japan recombinant protein market on the basis of end user?
• What are the various stages in the value chain of the Japan recombinant protein market?
• What are the key driving factors and challenges in the Japan recombinant protein?
• What is the structure of the Japan recombinant protein market and who are the key players?
• What is the degree of competition in the Japan recombinant protein market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Recombinant Protein Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Recombinant Protein Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Recombinant Protein Market - Breakup by Product

• 6.1 Antibodies
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Hormones
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Growth Factors
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Cytokines
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)
• 6.5 Others
  • 6.5.1 Historical and Current Market Trends (2019-2024)
  • 6.5.2 Market Forecast (2025-2033)

7 Japan Recombinant Protein Market - Breakup by Application

• 7.1 Drug Discovery and Development
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Academic Research
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Biotechnology Research
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Biopharmaceutical Production
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Others
  • 7.5.1 Historical and Current Market Trends (2019-2024)
  • 7.5.2 Market Forecast (2025-2033)

8 Japan Recombinant Protein Market - Breakup by End User

• 8.1 Pharmaceutical and Biopharmaceutical Companies
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 Biotechnology Companies
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Academic and Research Institutes
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Contract Research Organization
  • 8.4.1 Overview
  • 8.4.2 Historical and Current Market Trends (2019-2024)
  • 8.4.3 Market Forecast (2025-2033)
• 8.5 Others
  • 8.5.1 Historical and Current Market Trends (2019-2024)
  • 8.5.2 Market Forecast (2025-2033)

9 Japan Recombinant Protein Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Product Portfolio
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Product Portfolio
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Product Portfolio
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Product Portfolio
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Product Portfolio
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Recombinant Protein Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix